JENNIFER MIJANGO: Open Payments
NPI 1457928285 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $311 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 21 | $602 |
| Gilead Sciences, Inc. | 20 | $512 |
| ABBVIE INC. | 1 | $123 |
| Novo Nordisk Inc | 1 | $121 |
| Vertex Pharmaceuticals Incorporated | 1 | $118 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| Melinta Therapeutics, LLC | 3 | $74 |
| Shionogi Inc | 3 | $57 |
| Insmed, Inc. | 1 | $28 |
Products named: CABENUVA, QULIPTA, Wegovy, DOVATO, APRETUDE, Rezzayo, ZERBAXA, Fetroja.
Industry payments across VA — which companies pay providers there.
